Pharma-Bio Serv Inc (PBSV)
0.70
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 16.07M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -27.28% |
Valuation | |
PE Ratio | 25.93 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.065 |
Price to Book Value | 1.135 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.075 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 69.52% |
Profile
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries. |
URL | https://www.pharmabioserv.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | N/A |
Last Earnings Release | Jan. 29, 2018 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jan. 29, 2024 |
Ratings
Profile
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries. |
URL | https://www.pharmabioserv.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | N/A |
Last Earnings Release | Jan. 29, 2018 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Jan. 29, 2024 |